{
    "2018-01-21": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "Pfizer",
                        "comparison",
                        "investment opportunity"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them",
                "features": {
                    "keywords": [
                        "highest-growth drugs",
                        "2018",
                        "rich",
                        "pharmaceutical growth"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}